In several neurodegenerative diseases, i.e., AD, PD, Huntington's disease, and ALS, PARP1's pathological roles have been established, and the use of PARP1 inhibitors as treatment has shown some promise. The gene discussed is PARP1; the disease is neurodegenerative disease.